Self-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform

ACS Nano

Volumn 2, Issue 8, 2008, Pages 1696-1702

  Zhang, Liangfang ^a   Chan, Juliana M ^a   Gu, Frank X ^a   Rhee, June Wha ^b   Wang, Andrew Z ^a,b   Radovic Moreno, Aleksandar F ^a   Alexis, Frank ^a,b   Langer, Robert ^a   Farokhzad, Omid C ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Drug delivery; Liposome; Nanoprecipitation; Polymeric nanoparticle; Self assembly

Indexed keywords

CHEMOTHERAPY; DRUG DELIVERY; DRUG PRODUCTS; ENCAPSULATION; NANOPARTICLES; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES; NUCLEAR PROPULSION; POLYMERS; SELF ASSEMBLY; SHELLS (STRUCTURES); TECHNOLOGY;

DIFFERENTIAL TARGETING; DRUG ENCAPSULATION; DRUG ENCAPSULATION EFFICIENCY; DRUG LOADINGS; DRUG RELEASES; DRUG RETENTION; FUNCTIONAL COMPONENTS; LIPID MONOLAYERS; LIPOSOME; NANOPRECIPITATION; NANOPRECIPITATION METHOD; POLYMER HYBRIDS; POLYMERIC NANOPARTICLE; POLYMERIC SHELLS; SCALE-UP; SELF- ASSEMBLIES; SELF-ASSEMBLED; SERUM STABILITY; SINGLE-STEP; SUSTAINED DRUG RELEASE; SYSTEMIC CIRCULATION; WATER-SOLUBLE DRUGS;

DRUG DOSAGE;

DRUG; DRUG CARRIER; LIPID; NANOMATERIAL; POLYMER;

ARTICLE; CHEMISTRY; CONFORMATION; CRYSTALLIZATION; DIFFUSION; DRUG DESIGN; HYDROPHOBICITY; MACROMOLECULE; MATERIALS TESTING; METHODOLOGY; NANOMEDICINE; PARTICLE SIZE; SOLUBILITY; SURFACE PROPERTY; ULTRASTRUCTURE;

CRYSTALLIZATION; DIFFUSION; DRUG CARRIERS; DRUG DESIGN; HYDROPHOBICITY; LIPIDS; MACROMOLECULAR SUBSTANCES; MATERIALS TESTING; MOLECULAR CONFORMATION; NANOMEDICINE; NANOSTRUCTURES; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; POLYMERS; SOLUBILITY; SURFACE PROPERTIES;

EID: 51849084844     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn800275r     Document Type: Article

References (20)

1. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges. Nat. Rev. Cancer 2005, 5, 161-171.
2. Langer, R. Drug Delivery and Targeting. Nature 1998, 392, 5-10.
3. Jiang, W.; Kim, B. Y. S.; Rutka, J. T.; Chan, W. C. W. Nanoparticle-Mediated Cellular Response is Size-Dependent. Nat. Nanotechnol. 2008, 3, 145-150.
4. Farokhzad, O. C.; Langer, R. Nanomedicine: Developing Smarter Therapeutic and Diagnostic Modalities. Adv. Drug Delivery Rev. 2006, 58, 1456-1459.
5. Zhang, L.; Gu, F. X.; Chan, J. M.; Wang, A. Z.; Langer, R. S.; Farokhzad, O. C. Nanoparticles in Medicine: Therapeutic Applications and Developments. Clin. Pharmacol. Ther. 2008, 83, 761-769.
6. Wagner, V.; Dullaart, A.; Bock, A. K.; Zweck, A. The Emerging Nanomedicine Landscape. Nat. Biotechnol. 2006, 24, 1211-1217.
7. Farokhzad, O. C.; Cheng, J.; Teply, B. A.; Sherifi, I.; Jon, S.; Kantoff, P. W.; Richie, J. P.; Langer, R. Targeted Nanoparticle-Aptamer Bioconjugates for Cancer Chemotherapy in Vivo. Proc. Natl. Acad Sci. U.S.A. 2006, 103, 6315-6320.
8. Torchilin, V. P. Micellar Nanocarriers: Pharmaceutical Perspectives. Pharm. Res. 2007, 24, 1-16.
9. Tong, R.; Cheng, J. J. Anticancer Polymeric Nanomedicines. Polym. Rev. 2007, 47, 345-381.
10. Kim, T. Y.; Kim, D. W.; Chung, J. Y.; Shin, S. G.; Kim, S. C.; Heo, D. S.; Kim, N. K.; Bang, Y. J. Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies. Clin. Cancer Res. 2004, 10, 3708-3716.
11. Moghimi, S. M.; Szebeni, J. Stealth Liposomes and Long Circulating Nanoparticles: Critical Issues in Pharmacokinetics, Opsonization and Protein-Binding Properties. Prog. Lipid Res. 2003, 42, 463-478.
12. Torchilin, V. P. Recent Advances with Liposomes as Pharmaceutical Carriers. Nat. Rev. Drug Discovery 2005, 4, 145-160.
13. Skubitz, K. M. Phase II Trial of Pegylated-Liposomal Doxorubicin (Doxil) in Sarcoma. Cancer Invest. 2003, 21, 167-176.
14. De Miguel, I.; Imbertie, L.; Rieumajou, V.; Major, M.; Kravtzoff, R.; Betbeder, D. Proofs of the Structure of Lipid Coated Nanoparticles (SMBV) Used as Drug Carriers. Pharm. Res. 2000, 17, 817-824.
15. Wong, H. L.; Benclayan, R.; Rauth, A. M.; Wu, X. Y. Simultaneous Delivery of Doxorubicin and GG918 (Elacridar) by New Polymer-Lipid Hybrid Nanoparticles (PLN) for Enhanced Treatment of Multidrug-Resistant Breast Cancer. J. Controlled Release 2006, 116, 275-284.
16. Thevenot, J.; Troutier, A. L.; David, L.; Delair, T.; Ladaviere, C. Steric Stabilization of Lipid/Polymer Particle Assemblies by Poly(ethylene glycol)-Lipids. Biomacromolecules 2007, 8, 3651-3660.
17. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-Circulating and Target-Specific Nanoparticles: Theory to Practice. Pharmacol. Rev. 2001, 53, 283-318.
18. Gu, F.; Zhang, L.; Teply, B. A.; Mann, N.; Wang, A.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Precise Engineering of Targeted Nanoparticles by Using Self-Assembled Biointegrated Block Copolymers. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 2586-2591.
19. Lupold, S. E.; Hicke, B. J.; Lin, Y.; Coffey, D. S. Identification and Characterization of Nuclease-Stabilized RNA Molecules That Bind Human Prostate Cancer Cells via the Prostate-Specific Membrane Antigen. Cancer Res. 2002, 62, 4029-4033.
20. Zhang, L.; Radovic-Moreno, A. F.; Alexis, F.; Gu, F. X.; Basto, P. A.; Bagalkot, V.; Jon, S.; Langer, R. S.; Farokhzad, O. C. Co-Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle-Aptamer Bioconjugates. ChemMedChem 2007, 2, 1268-1271.